Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation
Authors:
- V. Wee YongVYV. Wee Yong
- 1 March 2009
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (3) , 898-909
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitroJournal of Neuroimmunology, 2008
- Collagenase-2 Deficiency or Inhibition Impairs Experimental Autoimmune Encephalomyelitis in MiceJournal of Biological Chemistry, 2008
- The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseJournal of Experimental Medicine, 2008
- Multifaceted aspects of inflammation in multiple sclerosis: The role of microgliaJournal of Neuroimmunology, 2007
- Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: Peripheral versus in situ immunoregulationJournal of Neuroimmunology, 2007
- Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammationJournal of Leukocyte Biology, 2007
- Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitisJournal of Experimental Medicine, 2006
- An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarizationThe FASEB Journal, 2005
- Resistance of young gelatinase B–deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesionsJournal of Clinical Investigation, 1999
- Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.Journal of Experimental Medicine, 1990